Setting a clear psychedelic intention can help shape your experience.
We can maximize insights and transformations with effective intention-setting.
Read morePreparing for a Psychedelic Experience
Here are some tips on preparing for your experience.
Read moreNext-Gen Psilocybin
CYB003 is a next-generation psilocybin designed to provide a faster onset of action and to reduce the duration of effects, ultimately thinning the financial barrier to access of this medicine in a medical setting.
The trial’s interim data demonstrated “rapid, robust, and clinically significant reduction of depression symptoms” three weeks after a single 12mg dose of CYB003.
Read morePsychedelics and Psychosis
In the 1960s, psychedelic research was driven underground. Now it’s re-emerging – with lessons for the study of psychosis.
Read moreHistory of Ibogaine
Author Julien Bonhomme, Ph.D explores how Euro-American psychedelic communities have appropriated Bwiti ibogaine rituals, creating a liminal experience that incorporates from both traditions.
Click here for the full article.
Read morePodcast: Metaplasticity and Reopening Critical Periods with Psychedelics
This podcast discusses how psychedelics reopen critical periods of learning, and how the true benefit of psychedelics could be in learning how best to reopen those critical periods, how long they’re open for, and which therapeutic frameworks and integration practices could best take advantage of them.
Read morePodcast: The Shadow Side of Psychedelics
how the nature of capitalism and returning profits to shareholders affects the concept of set and setting; how easy it is to prescribe ketamine and the puppy mill clinics popping up everywhere; how innovators are racing to the bottom to get ahead; the designer drug epidemic likely leading us to a Prozac Nation 2.0; digital narcissism, Instagram “Shamans,” and the dangers of cults; chemists trying to take the experience out of the drug; the overuse of psychedelics creating super egos; and much more.
Read moreRisks with Psychedelics
The most common forms of extended difficulty were feelings of anxiety and fear, existential struggle, social disconnection, depersonalization and derealization.
For approximately one-third of the participants, problems persisted for over a year, and for a sixth, they endured for more than three years.
It was found that a shorter duration of difficulties was predicted by knowledge of dose, drug type and lower levels of difficulty reported during the psychoactive experience, while a narrower range of difficulties was predicted by taking the drug in a guided setting.
Read moreIntensity of Psychedelic Experience
A new study suggests that dosage, age, and neuroticism may predict the intensity of a psychedelic experience, whether mystical (positive) or challenging.
Read morePsychedelics for Addiction?
Grinspoon discusses recovery, addiction and whether psychedelics might have a role in addiction treatment.
Read moreHPPD: Hallucinogen-Persisting Perception Disorder
Here’s a look at HPPD, the persistence of psychedelic-like perceptual phenomena after the acute effects of a psychedelic have worn off. It may be rare, but it is a risk and not well understood.
Read more